Cohort Study: High-sensitivity Troponin I after cardiac surgery and 30-day mortality.

High-Sensitivity Troponin I after Cardiac Surgery and 30-Day Mortality – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries:

Better assessment of risk from heart surgery results in better patient outcomes – McMaster University

NEJM study evaluates levels of HS Troponin after cardiac surgery and risk of death – MedicalResearch

Related: Retrospective cohort: Serial high-sensitivity cardiac troponin I after coronary artery bypass grafting may add prognostic information for post-operative decision-making.

Commentary on Twitter

The levels of high-sensitivity troponin I associated with an increased risk of death within 30 days after cardiac surgery are higher than levels currently used to define clinically important periprocedural myocardial injury. https://t.co/bnwPzQmh1h pic.twitter.com/pdmx23jPdz

— NEJM (@NEJM) March 2, 2022